ストックスクリーナーアプリを入手
7.26
0.14%
0.010
Ataibeckley Inc (ATAI) 最新ニュース
CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Sahm
Atai Beckley (NASDAQ:ATAI): What Does the Latest Update Mean for Trial Progress? - Kalkine Media
Deutsche Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $8 - Moomoo
Deutsche Bank Downgrades AtaiBeckley to Hold From Buy, Adjusts PT to $8 From $12 - marketscreener.com
AtaiBeckley Inc. Stock 12‑Month Price Target Cut to $8.83, Implies 22% Upside - TradingView
ATAI SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
AtaiBeckley Inc reports results for the quarter ended June 30Earnings Summary - TradingView
AtaiBeckley Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ATAI Beckley earnings on deck as investors eye Lilly deal By Investing.com - Investing.com UK
Eli Lilly, AtaiBeckley filed US premerger forms July 29, got German approval July 30 - MLex
AtaiBeckley (NASDAQ: ATAI) backs $6.75 cash sale to Lilly plus CVR upside - Stock Titan
Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's What You Should Know - Yahoo Finance
AtaiBeckley Inc. (ATAI): Investor Outlook with a 33.53% Potential Upside Amid Clinical Innovations - DirectorsTalk Interviews
Tracking Cathie Wood: Adding Intellia and SpaceX, Selling Off AtaiBeckley and Palantir - Moomoo
Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? - Morningstar
BlackRock, Inc. Adds to AtaiBeckley Inc (ATAI) Stake -- Shares F - GuruFocus
AtaiBeckley Inc. (ATAI) Stock Analysis: Navigating Challenges with a Potential 33.53% Upside - DirectorsTalk Interviews
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. - Yahoo Finance
ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly - True North Radio Network
BlackRock (ATAI holder) reports 24.99M ATAIBECKLEY shares, a 6.8% position - Stock Titan
AtaiBeckley(ATAI) Stock Options Chain | Quotes & News - Moomoo
Tracking Cathie Wood: Slashing AtaiBeckley and Figma, Betting on Gene-Editor Scribe Therapeutics - Moomoo
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too? - Stocktwits
Why Is ATAI Stock Soaring 59% After-Hours? - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – MUN:B72 - TradingView
AtaiBeckley Inc. Revenue Breakdown – FWB:B72 - TradingView
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView
Why Did AAPL, ATAI, UNH Stocks Jump To 52-Week Highs Today? - Stocktwits
Is AtaiBeckley (ATAI) A Bargain On Eli Lilly’s Takeover Deal? - simplywall.st
AtaiBeckley Inc. (ATAI) stock price, news, quote and history - Yahoo Finance UK
Form DEF 14A ATAI Beckley Inc For: 23 July By Investing.com - Investing.com Canada
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33% - Yahoo Finance
Key facts: Zepbound tops Wegovy; Novo sues; Lilly buys AtaiBeckley - TradingView
Lilly-AtaiBeckley Deal A Stamp Of Approval For Psychedelics - Law360
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? - TradingView
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal By Investing.com - Investing.com India
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal - Investing.com UK
Tracking Cathie Wood: Backing Prime Medicine and SpaceX, Sells Off AtaiBeckley, Shopify - Moomoo
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal - Global Legal Chronicle
AtaiBeckley (NASDAQ:ATAI) shares reflect 18% implied value for acquisition milestone entitlements - TechStock²
ATAIBECKLEY INC : BERENBERG CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $7.45 FROM $14 - Bitget
AtaiBeckley (ATAI) H.C. Wainwright 26th Annual Global Investment Conference 2024 summary - Quartr
ATAIBECKLEY INC : TD COWEN CUTS TO HOLD FROM BUY - Bitget
H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5 - Moomoo
J&J, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal - Endpoints News
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term Upside - TradingView
TD Cowen Downgrades AtaiBeckley to Hold From Buy - Moomoo
Berenberg Downgrades AtaiBeckley to Hold From Buy, Adjusts Price Target to $7.45 From $14 - marketscreener.com
Lilly Joins Psychedelic Drug Race With AtaiBeckley Buyout – Merger Arbitrage Mondays (NASDAQ:ATAI) - Seeking Alpha
Weekly Recap: Eli Lilly acquisition of AtaiBeckley and BPL-003 Phase 3 - TradingView
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):